LDT Case Could Provide First Look At Post-Chevron Arguments On FDA Regs

The first indication of how the Biden administration will work around the Supreme Court’s recent overcome of Chevron doctrine could come from the key lawsuit FDA faces over its laboratory developed test rule, as courts are no longer required to give deference to the agency’s perspective in interpreting the law. A lab group that filed a lawsuit over the LDT rule is likely to introduce post- Chevron arguments in a motion for summary judgment due Sept. 3. Legal experts...